DUPILUMAB (Dupixent®)
Clinical Indication
Type 2 inflammation in asthma inadequately controlled by high dose ICS
Comments
As part of FOC scheme
Date of classification
October 2020
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.